There was a trend to increased occurrence of insomnia in the immunotherapy arms (OR 1.40, 95% CI 0.90-2.18) that however failed to reach statistical significance.
← all excerpts
Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis.
1
—
—